Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
17.09
-1.56 (-8.36%)
Mar 31, 2025, 1:29 PM EDT - Market open
Tectonic Therapeutic Employees
Tectonic Therapeutic had 51 employees as of December 31, 2024. The number of employees increased by 7 or 15.91% compared to the previous year.
Employees
51
Change (1Y)
7
Growth (1Y)
15.91%
Revenue / Employee
n/a
Profits / Employee
-$1,136,902
Market Cap
318.95M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 51 | 7 | 15.91% |
Dec 31, 2023 | 44 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TECX News
- 10 days ago - Tectonic Therapeutic Announces Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 7 weeks ago - Tectonic: Expansion Of TX45 Candidate Possible After Positive Interim Data - Seeking Alpha
- 2 months ago - Tectonic Announces $185 Million Private Placement - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF - GlobeNewsWire
- 3 months ago - Tectonic Therapeutic: Protein Engineering Platform For GPCRs - Seeking Alpha
- 4 months ago - Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024 - GlobeNewsWire
- 4 months ago - Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference - GlobeNewsWire
- 5 months ago - Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein - GlobeNewsWire